UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31,June 30, 2023
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 333-257323
| SPECIFICITY, INC. | ||
| (Exact name of registrant as specified in its charter) | ||
| Nevada | 85-4017786 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| 410 S. Ware Blvd., Suite 508, Tampa, FL | 33619 | |
| (Address of principal executive offices) | (Zip Code) | |
| (813) 364-4744 | ||
| (Registrant’s telephone number, including area code) | ||
N/A
(Former name, former address, and former fiscal year, if changed since last report)
Securities Registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Common Stock | SPTY | OTCQB |
Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated Filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: shares of common stock as of May 11,June 30, 2023.
SPECIFICITY, INC.
TABLE OF CONTENTS
-i-i
SPECIFICTY, INC.
FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED MARCH 31,JUNE 30, 2023 AND 2022
INDEX TO FINANCIAL STATEMENTS
(UNAUDITED)
| Pages | |
| Balance Sheets | F- |
| Statements of Operations | F- |
| Statement of Stockholders’ Equity (Deficit) | F-4 |
| Statement of Cash Flows | F- |
| Notes to the Financial Statements | F-6 |
F-1
SPECIFICITY, INC
BALANCE SHEETS
(UNAUDITED)
| As of June 30, 2023 | As of December 31, 2022 | |||||||
| Assets: | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 8,711 | $ | 22,818 | ||||
| Accounts receivable | 44,000 | 8,182 | ||||||
| Prepaid expenses and other current assets | 8,860 | 235,375 | ||||||
| Total current assets | 61,571 | 266,375 | ||||||
| Property and equipment, net | 65,528 | 70,722 | ||||||
| Right of use asset | 43,842 | 64,632 | ||||||
| Total assets | $ | 170,941 | $ | 401,729 | ||||
| Liabilities and Stockholders’ Deficit: | ||||||||
| Current liabilities: | ||||||||
| Account payable | $ | 233,226 | $ | 93,867 | ||||
| Accrued liabilities | 41,172 | 37,828 | ||||||
| Accrued interest, related party | 25,000 | - | ||||||
| Note payable | 92,120 | - | ||||||
| Related party advances | 371,239 | 193,739 | ||||||
| Convertible note payable, net discount of $15,000 | 205,000 | - | ||||||
| Right of use liability | 43,842 | 43,909 | ||||||
| Total current liabilities | 1,011,599 | 369,343 | ||||||
| Long term liabilities - | ||||||||
| Related party notes payable | 1,000,000 | 1,000,000 | ||||||
| Right of use liability, net of current portion | - | 20,723 | ||||||
| Total liabilities | 2,011,599 | 1,390,066 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ Deficit: | ||||||||
| Preferred stock, Series A; $ par value; shares authorized; shares issued and outstanding as of June 30, 2023 and December 31, 2022 | 1,000 | 1,000 | ||||||
| Preferred stock, Series B; $par value; and shares authorized; and shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 1,400,000 | 1,400,000 | ||||||
| Common stock, $par value; shares authorized, and shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 10,682 | 10,652 | ||||||
| Additional paid-in capital | 4,476,383 | 4,401,413 | ||||||
| Accumulated deficit | (7,728,723 | ) | (6,801,402 | ) | ||||
| Total stockholders’ deficit | (1,840,658 | ) | (988,337 | ) | ||||
| Total liabilities and stockholders’ deficit | $ | 170,941 | $ | 401,729 | ||||
See accompanying notes to the financial statements.
F-1F-2
SPECIFICITY, INC
STATEMENTS OF OPERATIONS
(UNAUDITED)
SPECIFICITY, INC
BALANCE SHEETS
(UNAUDITED)
| As of March 31, 2023 | As of December 31, 2022 | |||||||
| Assets: | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 50,089 | $ | 22,818 | ||||
| Accounts receivable | - | 8,182 | ||||||
| Prepaid expenses and other current assets | 108,759 | 235,375 | ||||||
| Total current assets | 158,848 | 266,375 | ||||||
| Property and equipment, net | 68,139 | 70,722 | ||||||
| Right of use asset | 54,276 | 64,632 | ||||||
| Total assets | $ | 281,263 | $ | 401,729 | ||||
| Liabilities and Stockholders’ Deficit: | ||||||||
| Current liabilities: | ||||||||
| Account payable | $ | 90,114 | $ | 93,867 | ||||
| Accrued liabilities | 33,576 | 37,828 | ||||||
| Accrued interest, related party | 12,500 | - | ||||||
| Note payable | 104,770 | - | ||||||
| Related party advances | 368,172 | 193,739 | ||||||
| Right of use liability | 44,233 | 43,909 | ||||||
| Total current liabilities | 653,365 | 369,343 | ||||||
| Long term liabilities - | ||||||||
| Related party notes payable | 1,000,000 | 1,000,000 | ||||||
| Right of use liability, net of current portion | 10,043 | 20,723 | ||||||
| Total liabilities | 1,663,408 | 1,390,066 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ Deficit: | ||||||||
| Preferred stock, Series A; $ par value; shares authorized; shares issued and outstanding as of March 31, 2023 and December 31, 2022 | 1,000 | 1,000 | ||||||
| Preferred stock, Series B; $ par value; and shares authorized; and shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively | 1,400,000 | 1,400,000 | ||||||
| Common stock, $ par value; shares authorized, and shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively | 10,682 | 10,652 | ||||||
| Additional paid-in capital | 4,476,383 | 4,401,413 | ||||||
| Accumulated deficit | (7,270,210 | ) | (6,801,402 | ) | ||||
| Total stockholders’ deficit | (1,382,145 | ) | (988,337 | ) | ||||
| Total liabilities and stockholders’ deficit | $ | 281,263 | $ | 401,729 | ||||
| For the Three Months Ended June 30, 2023 | For the Three Months Ended June 30, 2022 | For the Six Months Ended June 30, 2023 | For the Six Months Ended June 30, 2022 | |||||||||||||
| Revenue, net | $ | 279,188 | $ | 378,660 | $ | 485,046 | $ | 649,510 | ||||||||
| Cost of revenues | 142,995 | 110,360 | 237,200 | 261,250 | ||||||||||||
| Gross profit | 136,193 | 268,300 | 247,846 | 388,260 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Sales and marketing | 45,930 | 19,837 | 56,010 | 32,717 | ||||||||||||
| General and administrative expenses, including stock based compensation of $, $, $ and $, respectively | 408,093 | 587,611 | 969,134 | 1,922,740 | ||||||||||||
| Officer compensation | 44,773 | 20,988 | 61,273 | 116,518 | ||||||||||||
| Total operating expenses | 498,796 | 628,436 | 1,086,417 | 2,071,975 | ||||||||||||
| Loss from operations | (362,603 | ) | (360,136 | ) | (838,571 | ) | (1,683,715 | ) | ||||||||
| Other income (expense): | ||||||||||||||||
| Interest expense | (70,650 | ) | (12,466 | ) | (88,750 | ) | (23,014 | ) | ||||||||
| Total other income (expense) | (70,650 | ) | (12,466 | ) | (88,750 | ) | (23,014 | ) | ||||||||
| Net loss | $ | (433,253 | ) | $ | (372,602 | ) | $ | (927,321 | ) | $ | (1,706,729 | ) | ||||
| Basic and diluted net loss per common share attributable to common stockholders | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Weighted-average number of shares used in computing basic and diluted per share amounts | ||||||||||||||||
See accompanying notes to the financial statements.
F-2F-3
SPECIFICITY, INC
STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022
(UNAUDITED)
STATEMENTS OF OPERATIONS
(UNAUDITED)
| Total | ||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Series A | Preferred Stock, Series B | Common Stock | Additional | Accumulated | Stockholders’ | |||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Deficit | Deficit | ||||||||||||||||||||||||||||||||
| Balance, December 31, 2022 | 1,000,000 | $ | 1,000 | 560,000 | $ | 1,400,000 | 10,652,584 | $ | 10,652 | $ | 4,401,413 | $ | - | $ | (6,801,402 | ) | (988,337 | ) | ||||||||||||||||||||||
| Issuance of common stock for cash | - | - | - | - | 30,000 | 30 | 74,970 | - | - | 75,000 | ||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | (927,321 | ) | (927,321 | ) | ||||||||||||||||||||||||||||
| Balance, June 30, 2023 | 1,000,000 | $ | 1,000 | 560,000 | $ | 1,400,000 | 10,682,584 | $ | 10,682 | $ | 4,476,383 | $ | - | $ | (7,728,723 | ) | $ | (1,840,658 | ) | |||||||||||||||||||||
| For the Three Months Ended March 31, 2023 | For the Three Months Ended March 31, 2022 | |||||||
| Revenue, net | $ | 231,118 | $ | 270,850 | ||||
| Cost of revenues | 94,205 | 150,890 | ||||||
| Gross profit | 136,913 | 119,960 | ||||||
| Operating expenses: | ||||||||
| Sales and marketing | 10,080 | 12,880 | ||||||
| General and administrative expenses, including stock based compensation of $ and $, respectively | 561,041 | 1,335,129 | ||||||
| Officer compensation | 16,500 | 95,530 | ||||||
| Total operating expenses | 587,621 | 1,443,539 | ||||||
| Loss from operations | (450,708 | ) | (1,323,579 | ) | ||||
| Other income (expense): | ||||||||
| Interest expense | (18,100 | ) | (10,548 | ) | ||||
| Total other income (expense) | (18,100 | ) | (10,548 | ) | ||||
| Net loss | $ | (468,808 | ) | $ | (1,334,127 | ) | ||
| Basic and diluted net loss per common share attributable to common stockholders | $ | (0.04 | ) | $ | (0.15 | ) | ||
| Weighted-average number of shares used in computing basic and diluted per share amounts | 10,652,584 | 8,875,895 | ||||||
| Total | ||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Series A | Preferred Stock, Series B | Common Stock | Additional | Accumulated | Stockholders’ | |||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Deficit | Deficit | ||||||||||||||||||||||||||||||||
| Balance, March 31, 2023 | 1,000,000 | $ | 1,000 | 560,000 | $ | 1,400,000 | 10,682,584 | $ | 10,682 | $ | 4,476,383 | $ | - | $ | (7,295,470 | ) | (1,407,405 | ) | ||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | (433,253 | ) | (433,253 | ) | ||||||||||||||||||||||||||||
| Balance, June 30, 2023 | 1,000,000 | $ | 1,000 | 560,000 | $ | 1,400,000 | 10,682,584 | $ | 10,682 | $ | 4,476,383 | $ | - | $ | (7,728,723 | ) | $ | (1,840,658 | ) | |||||||||||||||||||||
| Total | ||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Series A | Preferred Stock, Series B | Common Stock | Additional | Subscription | Accumulated | Stockholders’ | ||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Receivable | Deficit | Deficit | |||||||||||||||||||||||||||||||
| Balance, December 31, 2021 | 1,000,000 | $ | 1,000 | 260,000 | $ | 650,000 | 8,654,701 | $ | 8,655 | $ | 1,418,896 | $ | (1,500 | ) | $ | (2,456,870 | ) | $ | (379,819 | ) | ||||||||||||||||||||
| Issuance of common stock for cash | - | - | - | - | 314,644 | 314 | 471,653 | - | - | 471,967 | ||||||||||||||||||||||||||||||
| Offering costs | - | - | - | - | - | - | (22,831 | ) | - | - | (22,831 | ) | ||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | 400,000 | 400 | 599,600 | - | - | 600,000 | ||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | (1,706,729 | ) | (1,706,729 | ) | ||||||||||||||||||||||||||||
| Balance, June 30, 2022 | 1,000,000 | $ | 1,000 | 260,000 | $ | 650,000 | 9,369,345 | $ | 9,369 | $ | 2,467,318 | $ | (1,500 | ) | $ | (4,163,599 | ) | $ | (1,037,412 | ) | ||||||||||||||||||||
| Total | ||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Series A | Preferred Stock, Series B | Common Stock | Additional | Subscription | Accumulated | Stockholders’ | ||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Receivable | Deficit | Deficit | |||||||||||||||||||||||||||||||
| Balance, March 31, 2022 | 1,000,000 | $ | 1,000 | 260,000 | $ | 650,000 | 9,369,345 | $ | 9,369 | $ | 2,470,903 | $ | (1,500 | ) | $ | (3,790,997 | ) | $ | (661,225 | ) | ||||||||||||||||||||
| Offering costs | - | - | - | - | - | - | (3,585 | ) | - | - | (3,585 | ) | ||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | (372,602 | ) | (372,602 | ) | ||||||||||||||||||||||||||||
| Balance, June 30, 2022 | 1,000,000 | $ | 1,000 | 260,000 | $ | 650,000 | 9,369,345 | $ | 9,369 | $ | 2,467,318 | $ | (1,500 | ) | $ | (4,163,599 | ) | $ | (1,037,412 | ) | ||||||||||||||||||||
See accompanying notes to the financial statements.
F-3F-4
SPECIFICITY, INC
STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022(UNAUDITED)
(UNAUDITED)
| For the Six Months Ended June 30, 2023 | For the Six Months Ended June 30, 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net loss | $ | (927,321 | ) | $ | (1,706,729 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-based compensation | 233,505 | 600,000 | ||||||
| Depreciation | 5,194 | 4,769 | ||||||
| Debt discount amortization | 5,000 | - | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (35,818 | ) | - | |||||
| Prepaids and other current assets | (6,990 | ) | (3,557 | ) | ||||
| Accounts payable | 139,359 | (21,246 | ) | |||||
| Accrued liabilities | 3,344 | (10,333 | ) | |||||
| Accrued interest, related party | 25,000 | 12,466 | ||||||
| Net cash used in operating activities | (558,727 | ) | (1,124,630 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchase of property and equipment | - | (9,207 | ) | |||||
| Net cash used in investing activities | - | (9,207 | ) | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Proceeds from notes payable | 120,000 | - | ||||||
| Payments on notes payable | (27,880 | ) | - | |||||
| Advances from related party | 177,500 | 73,000 | ||||||
| Proceeds from convertible notes payable | 200,000 | - | ||||||
| Payment of deferred offering costs | - | (22,831 | ) | |||||
| Proceeds from sale of common stock | 75,000 | 471,967 | ||||||
| Net cash provided by financing activities | 544,620 | 522,136 | ||||||
| Change in cash and cash equivalents | (14,107 | ) | (611,701 | ) | ||||
| Cash and cash equivalents, beginning of period | 22,818 | 637,841 | ||||||
| Cash and cash equivalents, end of period | $ | 8,711 | $ | 26,140 | ||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for interest | $ | 73,750 | $ | 10,548 | ||||
| Cash paid for income taxes | $ | - | $ | - | ||||
| Non-cash investing and financing activities: | ||||||||
| Right of use asset and liability | $ | - | $ | 104,665 | ||||
| Total | ||||||||||||||||||||||||||||||||||||
| Preferred Stock, Series A | Preferred Stock, Series B | Common Stock | Additional | Accumulated | Stockholders’ | |||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Deficit | Deficit | ||||||||||||||||||||||||||||
| Balance, December 31, 2022 | 1,000,000.00 | $ | 1,000 | 560,000 | $ | 1,400,000 | 10,652,584 | $ | 10,652 | $ | 4,401,413 | $ | (6,801,402 | ) | (988,337 | ) | ||||||||||||||||||||
| Common shares issued for services | - | - | - | - | 30,000 | 30 | 74,970 | - | 75,000 | |||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (468,808 | ) | (468,808 | ) | |||||||||||||||||||||||||
| Balance, March 31, 2023 | 1,000,000.00 | $ | 1,000 | 560,000 | $ | 1,400,000 | 10,682,584 | $ | 10,682 | $ | 4,476,383 | $ | (7,270,210 | ) | $ | (1,382,145 | ) | |||||||||||||||||||
See accompanying notes to the financial statements.
F-4
SPECIFICITY, INC
STATEMENTS OF CASH FLOWS
(UNAUDITED)
| For the Three Months Ended March 31, 2023 | For the Three Months Ended March 31, 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net loss | $ | (468,808 | ) | $ | (1,334,127 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-based compensation | 137,356 | 600,000 | ||||||
| Depreciation | 2,583 | 2,246 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 8,182 | - | ||||||
| Related party receivables | - | - | ||||||
| Prepaids and other current assets | (10,740 | ) | (11,349 | ) | ||||
| Accounts payable | (3,753 | ) | 42,646 | |||||
| Accrued liabilities | (4,252 | ) | (36,079 | ) | ||||
| Net cash used in operating activities | (326,932 | ) | (736,663 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchase of property and equipment | - | (9,207 | ) | |||||
| Net cash used in investing activities | - | (9,207 | ) | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Net borrowings on notes payable | 104,770 | - | ||||||
| Advances from related party | 174,433 | - | ||||||
| Payment of deferred offering costs | - | (19,246 | ) | |||||
| Proceeds from sale of common stock | 75,000 | 471,967 | ||||||
| Net cash provided by financing activities | 354,203 | 452,721 | ||||||
| Change in cash and cash equivalents | 27,271 | (293,149 | ) | |||||
| Cash and cash equivalents, beginning of period | 22,818 | 637,841 | ||||||
| Cash and cash equivalents, end of period | $ | 50,089 | $ | 344,692 | ||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for interest | $ | 3,100 | $ | 10,548 | ||||
| Cash paid for income taxes | $ | - | $ | - | ||||
| Non-cash investing and financing activities: | ||||||||
| Right of use asset and liability | $ | - | $ | 104,665 | ||||
See accompanying notes to the financial statements.
F-5
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS
Specificity, Inc. (the “Company”) is a Nevada Corporation incorporated on November 25, 2020 (“Inception”).
The Company is a full-service digital marketing firm that delivers cutting-edge marketing solutions to business-to-business clients as well as business to consumer clients. The Company has developed tools that allow us to identify and market to people who are actively in the buying cycle. We take advantage of the real-time messaging opportunities digital marketing offers to give small and medium-sized businesses a fair chance at online traffic.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited interim consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these consolidated financial statements have been included. Such adjustments consist of normal recurring adjustments. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2022. The results of operations for the threesix months ended March 31,June 30, 2023 are not indicative of the results that may be expected for the full year.
Revenues for the three months ended March 31, 2023, were reduced by approximately $24,000 due to a cutoff error subsequently discovered. The amount is insignificant to the financial and will be corrected prospectively.
Use of Estimates
The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Concentration of Credit Risk
Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.
F-6
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
Fair Value Measurements
The Company follows FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) to measure and disclosure the fair value of its financial instruments. ASC 820 establishes a framework for measuring fair value in U.S. GAAP and expands disclosures about fair value measurements and establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The three levels of fair value hierarchy defined by ASC 820 are described below:
| Level 1 | Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. | |
| Level 2 | Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. | |
| Level 3 | Pricing inputs that are generally unobservable inputs and not corroborated by market data. |
Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.
The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
The carrying amounts reported in the Company’s financial statements for cash, accounts receivable, prepaids and other current assets, accounts payable, etc. approximate their fair value because of the immediate or short-term mature of these financial instruments.
Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period, increased by the potentially dilutive common shares that were outstanding during the period. As of March 31,June 30, 2023, the Company had warrants and approximately in potential shares under a convertible note which were excluded from the calculation as they would have been anti-dilutive. As of June 30, 2022, the Company doesdid t have any dilutive shares.
New Accounting Pronouncements
The FASB issues ASUs to amend the authoritative literature in ASC. There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.
NOTE 3 – GOING CONCERN
As reflected in the accompanying financial statements, during the threesix months ended March 31,June 30, 2023, the Company incurred a net loss of $468,808927,321 and used cash of $326,932558,727 in operating activities. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. We have evaluated the conditions or events that raise substantial doubt about the Company’s ability as a going concern within one year of issuance of the financial statements.
F-7
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
While the Company is continuing operations and generating revenues, the Company’s cash position is not significant enough to support the Company’s daily operations. To fund operations and reduce the working capital deficit, the Company has raised capital through the sale of common and preferred stock as well as monies advanced from related parties. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect, nor can there be assurance that such funds will be at acceptable terms. The ability of the Company to continue as a going concern is dependent upon our ability to further implement its business plan and generate revenues and cash flows. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
F-7
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 4 – FINANCIAL STATEMENT ELEMENTS
In 2020, the Company purchased software for which is to be used in operations with a $50,000 note payable. The software isn’tis not expected to be implemented until late-2023 and thus no amortization was recorded at March 31,June 30, 2023.
NOTE 5 –ADVANCES AND NOTES PAYABLE
On January 13, 2021, the Company entered into a share purchase agreement with the Company’s Chief Executive Officer to acquire % of Pickpocket, Inc. (“Pickpocket”) for a purchase price of $ million in the form of a promissory note. As of the date of acquisition, Pickpocket did not have any operations or significant assets. Upon acquisition, the Company expensed the $ million as compensation to officer. The transaction was accounted for on a carry-over basis as the Chief Executive Officer was the controlling shareholder in both entities. The promissory note incurs interest at a rate of % per annum. During the threesix months ended March 31,June 30, 2023 and 2022, the Company either accrued or paid interest of $. As of March 31,June 30, 2023, the Company has accrued interest of $ included within accrued interest, related party on the accompanying balance sheet.
The Company’s chief executive officer and a member of management have advanced the Company funds for operations. The advances do not incur interest and are due on demand. As of March 31,June 30, 2023, the balance due on the advances was $368,172371,239. Subsequent to March 31,June 30, 2023, additional advances were $$110,0000,000.00_..
On March 2, 2023, the Company entered into a revenue purchase agreement with a third party. Under the terms of the agreement, the Company received proceeds of $120,000 for which $169,200 will be repaid in 36 weekly installments of $4,700. The amounts loaned are secured by substantially all of the Company’s assets and are guaranteed by the Company’s Chief Executive Officer and a member of management. Subsequent to March 31, 2022,
On April 25, 2023, the Company entered into an additional agreement fora convertible promissory note with a principal amount of $220,000, of which $200,000 was received in proceeds. The $20,000 on-issuance discount was recorded as a discount to the note and is being amortized to interest expense over the term of the note. The convertible promissory note contains a one-time interest charge of 10% applied on the issuance date to the original principal amount. The principal and interest are due in fixed monthly payments of $26,889 from July 2023 through March 2024. The principal and accrued interest may be converted into shares of the Company’s common stock at a conversion price of $1.50 per share at any time while the note is outstanding. During the six months ended June 30, 2023, the Company recorded $5,000 in debt discount amortization with $15,000 remaining which will be amortized over the term of the note.
F-8
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 6 - COMMITMENTS AND CONTIGENCIES
Lease
The Company leases offices used for operations under a non-cancelable agreement. Rent expense for the threesix months ended March 31,June 30, 2023 and 2022 was $26,28048,595 and $35,05877,440, respectively. On January 1, 2022, the Company recorded a right of use asset and liability of $104,665. The Company used an effective borrowing rate of 33%% which is the annual increase per the lease agreement.
F-8
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
Litigation
The Company is not party to any pending or threatened litigation.
Significant Contracts
On January 1, 2021, the Company entered into an employment contract with its Chief Executive Officer for which the initial term of the agreement is for one year and renews automatically annually. If the Chief Executive Officer is terminated without cause, then the remaining current contract year shall be paid. During the threesix months ended March 31,June 30, 2023, and 2022 the Company accrued or paid either the Chief Executive Officer and/or entities affiliated with the Chief Executive Officer $16,50061,273, and $95,530116,518, respectively which has been classified as officer compensation on the accompanying statements of operations. As of March 31,June 30, 2023, amounts due to the Chief Executive Officer were $15,00025,000 and included within accrued liabilities on the accompanying balance sheet.
See Notes 5 and 7 for additional payments totransactions with the related party.
NOTE 7 –STOCKHOLDERS’ EQUITY (DEFICIT)
Series A Preferred Stock
The Company is authorized to issue shares of $ par value Series A preferred stock (“Series A”). The holder of the Series A preferred stock is entitled to 80% of all voting rights available at the time of any vote. In the event of liquidation or dissolution of the Company, holders of Series A preferred stock are entitled to share ratably in all assets remaining after payment of liabilities and have no liquidation preferences. Holders of Series A preferred stock have a right to convert each share of Series A into five shares common stock. See below for discussion regarding issuance of Series A preferred stock.
Series B Preferred Stock
The Company is authorized to issue 260,000 shares of $ par value Series B preferred stock (“Series A”). During September 2022, the Company increased the Series B preferred stock authorized shares to . The holder of the Series B preferred stock do not have voting rights. In the event of liquidation or dissolution of the Company, holders of Series B preferred stock are entitled to share ratably in all assets remaining after payment of liabilities and have no liquidation preferences. Holders of Series B preferred stock have a right to convert in the pro rata portion of exactly ten percent of the issued and outstanding common stock of the Company.
F-9
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
Common Stock
The Company is authorized to issue shares of $ par value common stock. The holders of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders.
During the threesix months ended March 31,June 30, 2022 the Company sold shares of common stock to various investors at prices ranging from $ to $ per share resulting in gross proceeds of $471,967. As of the three months ended March 31, 2022 there were no subscriptions receivable related to these sales. Offering costs related to the sale of these shares amounted to $19,246 as of March 31, 2022 during the six months ended June 30, 2022.
During the threesix months ended March 31,June 30, 2022, the Company issued shares of common stock to two employees for services rendered. The Company recorded $ as stock-based compensation, within general and administrative expense in connection with the issuance. The Company valued the shares based upon the recent sales of common stock.
During the six months ended June 30, 2023, the Company sold shares of common stock at $ per share resulting in proceeds of $75,000. In connection with the sale, the Company issued warrants to purchase 75,000 shares of common stock at an exercise price of $5.00. The warrants vested upon issuance and expire in two 2 years.
NOTE 8 – SUBSEQUENT EVENTS
Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that no material subsequent events exist other than those disclosed.
F-9F-10
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Note Regarding Forward-Looking Information and Factors That May Affect Future Results
This quarterly report on Form 10-Q contains forward-looking statements regarding our business, financial condition, results of operations and prospects. The Securities and Exchange Commission (the “SEC”) encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This quarterly report on Form 10-Q and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management’s plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated sales efforts, expenses, the outcome of contingencies, such as legal proceedings, and financial results. Factors that could cause our actual results of operations and financial condition to differ materially are set forth in the “Risk Factors” section of our Form S-1 filed with the Commission on September 13, 2022.
We caution that these factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q.
Business Overview
The discussion and analysis of our financial condition and results of operations are based on our financial statements, which we have prepared in accordance with accounting principles generally accepted in the United States of America. This discussion should be read in conjunction with the other sections of this Form 10-Q, including “Risk Factors” as described in our Form S-1 as filed with the Commission on September 13, 2022, and the Financial Statements. The various sections of this discussion contain a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risk factors described throughout our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Commission on March 30, 2023, and our Form S-1 as filed with the Commission on September 13, 2022. See “Forward-Looking Statements.” Our actual results may differ materially. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
As used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” except where the context otherwise requires, the term “we,” “us,” “our,” or “the Company,” refers to the business of Specificity, Inc.
-1-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
Organizational Overview
Specificity, Inc. (“Specificity” or the “Company”) was incorporated in the State of Nevada on November 25, 2020.
The Problem We Endeavor to Solve
Big Tech and the Social Media giants have all evolved away from client advocacy and moved into a new paradigm of fear and hyper political correctness. They no longer endeavor to do what is right for their marketing clients. Instead, they have made marketing to targeted audiences exponentially more difficult and dramatically more expensive.
After the fallout from the social media giants getting caught misusing user supplied data (for example Cambridge Analytica) they pulled most of the targeting mechanisms out of their platforms to avoid additional congressional oversight and regulation. They have since gone a step further by claiming the rationale for these changes is to stop discrimination.
We believe the real motivation for this policy change is not anti-discrimination, rather it is revenue driven. They are forcing ad delivery to consumers unlikely to buy. They are also forcing increased quantities of ads to be placed in order to hit an impactful number of targeted buyers. As a result, businesses are deploying the same budget with diminished results or are forced to increase their spend to keep the net results the same. Their claim is that using peoples’ interests and behavior to identify suitable audiences to market to is suddenly discriminatory. These companies have used these practices for well over a decade. Targeting buyers with incomes that suggest they can afford a six-figure sports car isn’t discrimination; it’s the responsible deployment of advertising spend. Conversely, delivery of ads for low-income housing opportunities to wealthy people makes just as little sense as well.
At best its political correctness run amuck at worst it’s a ploy to drive ad spend up by forcing people to spend more to get the same. And not only will we take no part in this, we are building Specificity specifically to help businesses get the very most for their ad spend. Our marketing tools will target those most likely to buy the product being solicited. We would never allow nor condone discrimination of any kind. But delivering advertising to people actively looking for products and services is NOT discrimination; it’s intelligent marketing.
Company Overview
Specificity, Inc. is a technology company with 2 core missions:
| 1) | First, we endeavor to deliver the latest digital marketing technology to companies of all sizes making them nationally, regionally, and locally competitive. In this capacity, we come to the table already vertically integrated and capable of executing any size campaign flawlessly. | |
| 2) | Secondarily, Specificity is a tech incubator. We identify technology-based marketing solutions, take an equity share position in return for utilizing our internal resources to complete the buildout of technology-based solutions, and then using our marketing prowess to draw clients to these businesses. We have the internal personnel to successfully complete these projects and our marketing capabilities will deliver lower advertising costs to launch new projects making growth faster to attain. |
-2-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
We are currently a development stage company with minimal revenues, though we had a significant increase in revenues for the year ended December 31, 2022. Accordingly, management has concluded that there is substantial doubt in our ability to continue as a going concern (please refer to the footnotes to the financial statements). As of March 31,June 30, 2023, the Company is still unable to establish a consistent flow of revenues from our operations which is sufficient to sustain our operating needs, management intends to rely primarily upon debt financing to supplement cash flows, if any, generated by our services. We will seek out such financing as necessary to allow the Company to continue to grow our business operations, and to cover such cost, excluding professional fees, associated with being a reporting Company with the Securities and Exchange Commission (“SEC”). The Company has included such costs to become a publicly reporting company in its targeted expenses for working capital expenses and intends to seek out reasonable loans from friends, family, and business acquaintances if it becomes necessary. At this point we have been funded by our founders and initial shareholders and have not received any firm commitments or indications from any family, friends, or business acquaintances regarding any potential investment in the Company except those shareholders listed herein.
Results of Operations – Three Months Ended March 31,June 30, 2023, vs 2022
Revenues
For the quarterthree months ended March 31,June 30, 2023, and the quarter ended March 31,June 30, 2022, we generated $231,118$279,188 and $270,850$378,660 in revenues, respectively. The decrease in revenues was due to a significant number of nonperforming salespeople which were subsequently released from employment as the Company shifted to engage larger clients. Additionally, several client launches which were anticipated to be completed during the firstsecond quarter of 2023 were delayed from completion by the quarter ended March 31,June 30, 2023, and are anticipated to be consummated during the third quarter of 2023. Our ongoing revenues and additional new business signed during June 2023 illuminates a revised run rate, defined as the monthly volume of sales annualized at the rate, of approximately $1,800,000 moving forward given the dynamic of our billing practice and client relationships.
Operating Expenses
For the three months ended June 30, 2023, and June 30, 2022, we incurred $498,796 and $628,436 in operating expenses, respectively. The decrease in Operating Expenses was due primarily to a decrease in general and administrative expenses.
Six Months Ended June 30, 2023, vs 2022
Revenues
For the six months ended June 30, 2023, and the six months ended June 30, 2022, we generated $485,046 and $649,510 in revenues, respectively. The decrease in revenues was due to a significant number of nonperforming salespeople which were subsequently released from employment as the Company shifted to engage larger clients. Additionally, several client launches which were anticipated to be completed during the second quarter of 2023 were delayed from completion by the quarter ended June 30, 2023, and are anticipated to be consummated during the third quarter of 2023.
Operating Expenses
For the quartersix months ended March 31,June 30, 2023, and the quartersix months ended March 31,June 30, 2022, we incurred $587,621$1,086,417 and $1,443,539$2,071,975 in operating expenses, respectively. The decrease in Operating Expenses was due primarily to a decrease in general and administrative expenses and a decrease in officer compensation due to the continued expansion of our operations.
Liquidity, Capital Resources, and Off-Balance Sheet Arrangements
Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had available cash on hand of $50,089$8,711 as of March 31,June 30, 2023, as compared to $344,692$26,140 as of March 31,June 30, 2022. The decrease in capital was directly related to a decrease in proceeds from the sale of common stock.
Cash flows for the threesix months ended March 31,June 30, 2023.
Net cash flow derived from operating activities was $(326,932)$(558,727) for the threesix months ended March 31,June 30, 2023. This is due primarily to a net loss of $468,808, account payable($927,321), accounts receivable of $(3,753)$(35,818), prepaids and other current assets of $(10,740)$(6,990), offset primarily by $137,356 in the$233,505 from stock-based compensation and $8,182 in accounts receivable. The increase from netcompensation. Net cash flow derived from operating activities was $(1,124,630) for the threesix months ended March 31,June 30, 2022, due primarily to a net loss of $(736,663) is primarily due to the expansion$(1,706,729), accounts payable of our operations.$(21,246) and accrued liabilities of $(10,333).
-3-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
Net cash flow used in investing activities was $0 for the threesix months ended March 31,June 30, 2023, and $(9,207) for the threesix months ended March 31,June 30, 2022, due primarily to the purchase of property or equipment totaling $(9,207) during the threesix months ended March 31,June 30, 2022.
Net cash provided by financing activities was $354,203$544,620 for the threesix months ended March 31,June 30, 2023, and consisted of $75,000 from the proceeds from the sale of common stock, $174,433$177,500 from advances from related parties and $104,770$320,000 from payments ontwo notes payable. Net cash provided by financing activities was $452,721$522,136 for the threesix months ended March 31,June 30, 2022, and consisted primarily of $471,967 from the proceeds from the sale of common stock. The Company continues to raise capital to fund operations.
Cash Requirements
Our management does not believe that our current capital resources will be adequate to continue operating our company and maintaining our business strategy for much more than 12 months. At the date hereof, we have minimal cash at hand. We require additional capital to implement our business and fund our operations.
Since inception we have funded our operations primarily through equity financing and we expect that we will continue to fund our operations through the equity and debt financing, either alone or through strategic alliances. Additional funding may not be available on favorable terms, if at all. We intend to continue to fund our business by way of equity or debt financing until natural revenues can support the Company. If we raise additional capital through the issuance of equity or convertible debt securities, the percentage ownership of our company held by existing shareholders will be reduced and those shareholders may experience significant dilution. In addition, new securities may contain certain rights, preferences or privileges that are senior to those of our common stock. We cannot assure you that we will be able to raise the working capital as needed in the future on terms acceptable to us, if at all.
If we are unable to raise capital as needed, we are required to reduce the scope of our business development activities, which could harm our business plans, financial condition, and operating results, or cease our operations entirely, in which case, you will lose all of your investment.
Off-Balance Sheet Arrangements
Not applicable.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure controls and procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports, filed under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, a control may become inadequate because of changes in conditions or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
-4-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
As required by the SEC Rules 13a-15(b) and 15d-15(b), we carried out an evaluation under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due to material weaknesses in internal controls over financial reporting.
To address these material weaknesses, management engaged financial consultants, performed additional analyses and other procedures to ensure that the financial statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.
A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Audit Standard No. 5, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that as of March 31,June 30, 2023, our internal controls over financial reporting were not effective at the reasonable assurance level:
1. We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us for the three months ended March 31,June 30, 2023. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.
2. We do not have sufficient resources in our accounting function, which restricts the Company’s ability to gather, analyze and properly review information related to financial reporting in a timely manner. In addition, due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.
3. We do not have personnel with sufficient experience with United States generally accepted accounting principles to address complex transactions.
4. We have inadequate controls to ensure that information necessary to properly record transactions is adequately communicated on a timely basis from non-financial personnel to those responsible for financial reporting. Management evaluated the impact of the lack of timely communication between non–financial personnel and financial personnel on our assessment of our reporting controls and procedures and has concluded that the control deficiency represented a material weakness.
5. We have determined that oversight over our external financial reporting and internal control over our financial reporting is ineffective. The Chief Financial Officer has not provided adequate review of the Company’s SEC’s filings and financial statements and has not provided adequate supervision and review of the Company’s accounting personnel or oversight of the independent registered accounting firm’s audit of the Company’s financial statement.
We have taken steps to remediate some of the weaknesses described above, including by engaging a financial reporting advisor with expertise in accounting for complex transactions. We intend to continue to address these weaknesses as resources permit.
Changes in internal control over financial reporting
There were no changes in our internal control over financial reporting during the quarter ended March 31,June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
-5-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We know of no material, existing, or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.
ITEM 1A. RISK FACTORS
As a smaller reporting company, we are not required to provide the information required by this item. However, please refer to our Form 10-K as filed with the Commission on March 30, 2023, and our Form S-1 as filed with the Commission on September 13, 2022, to see those Risk Factors listed therein.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Except for founders shares all unregistered shares have since been registered pursuant to the Form S-1 registration statement deemed effective on September 16, 2021, the Form S-1 registration statement deemed effective on June 1, 2022, and the Form S-1 Registration statement deemed effective on September 23, 2022.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
-6-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
ITEM 6. EXHIBITS
| Exhibit No. | Description of Exhibit | |
| 31.1* | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002. | |
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002. | |
| 101.INS* | XBRL INSTANCE DOCUMENT | |
| 101.SCH* | XBRL TAXONOMY EXTENSION SCHEMA | |
| 101.CAL* | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | |
| 101.DEF* | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | |
| 101.LAB* | XBRL TAXONOMY EXTENSION LABEL LINKBASE | |
| 101.PRE* | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE |
| * | Filed herewith. | |
-7-
SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Specificity, Inc. | ||
| Date: | By: | /s/ Jason Wood |
| Name: | Jason Wood | |
| Title: | Chairman of the Board of Directors, Chief Executive Officer, Chief Financial Officer (Principal Executive Officer) (Principal Financial and Accounting Officer) | |
-8-